Wednesday Apr 8, 2020
3:00 PM - 3:45 PM EDT
April 8
3:00 - 3:45 p.m.
Webinar
Register here.
New gene editing technologies have energized the science of drug discovery and sparked a wave of startups. With the advent of CRISPR/Cas9 systems, a researcher can find an active nuclease on virtually any region of the genome, greatly reducing the time needed to develop novel therapies to treat a wide range of diseases.
But increased choice can lead to problems in building a cell line model yielding the best results. In the first presentation, we’ll address common real-world challenges in cell line engineering and explore methods to avoid the pitfalls.
Printed courtesy of www.nclifesci.org/ – Contact the NC Life Sciences Organization for more information.
4505 Emperor Blvd, Ste 105, Durham, NC 27703 – (919) 281-8960 – Admin@NCLifeSci.org